Skip to Content

Dovato 50 mg / 300 mg tablets

Licence status
Authorised: 01/07/2019
Active substances
Dolutegravir sodium, Lamivudine
Dosage Form
Film-coated tablet
Licence number
EU/1/19/1370/001-002
Licence holder
ViiV Healthcare BV

Licence information

ATC code
J05AR25 dolutegravir sodium, Lamivudine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
01/07/2019